BRAF and melanoma: Furthermore, a higher expression of adipocyte enhancer-binding protein 1 (AEBP1) has been shown to confer resistance to BRAF inhibition in vivo, and greater CREB activation is required for AEBP1 overexpression in resistant melanoma cells [265].